Pacific Biosciences Of California Net Income 2010-2023 | PACB

Pacific Biosciences Of California net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Pacific Biosciences Of California Annual Net Income
(Millions of US $)
2023 $-307
2022 $-314
2021 $-181
2020 $29
2019 $-84
2018 $-103
2017 $-92
2016 $-74
2015 $-32
2014 $-66
2013 $-79
2012 $-94
2011 $-109
2010 $-140
2009 $-88
Pacific Biosciences Of California Quarterly Net Income
(Millions of US $)
2023-12-31 $-82
2023-09-30 $-67
2023-06-30 $-70
2023-03-31 $-88
2022-12-31 $-84
2022-09-30 $-77
2022-06-30 $-71
2022-03-31 $-81
2021-12-31 $-69
2021-09-30 $17
2021-06-30 $-41
2021-03-31 $-87
2020-12-31 $75
2020-09-30 $-24
2020-06-30 $-23
2020-03-31 $1
2019-12-31 $-0
2019-09-30 $-29
2019-06-30 $-25
2019-03-31 $-30
2018-12-31 $-31
2018-09-30 $-25
2018-06-30 $-23
2018-03-31 $-24
2017-12-31 $-21
2017-09-30 $-22
2017-06-30 $-26
2017-03-31 $-24
2016-12-31 $-19
2016-09-30 $-17
2016-06-30 $-18
2016-03-31 $-19
2015-12-31 $-1
2015-09-30 $2
2015-06-30 $-12
2015-03-31 $-20
2014-12-31 $-19
2014-09-30 $-9
2014-06-30 $-19
2014-03-31 $-19
2013-12-31 $-17
2013-09-30 $-20
2013-06-30 $-20
2013-03-31 $-21
2012-12-31 $-22
2012-09-30 $-23
2012-06-30 $-22
2012-03-31 $-28
2011-12-31 $-23
2011-09-30 $-29
2011-06-30 $-22
2011-03-31 $-35
2010-12-31 $-36
2010-09-30 $-41
2010-06-30 $-33
2010-03-31 $-30
2009-12-31
2009-09-30 $-25
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.370B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.237B 26.44
Intuitive Surgical (ISRG) United States $132.348B 79.73
DexCom (DXCM) United States $54.655B 83.14
Edwards Lifesciences (EW) United States $52.976B 34.51
IQVIA Holdings (IQV) United States $42.467B 25.19
IDEXX Laboratories (IDXX) United States $40.633B 48.58
Alcon (ALC) Switzerland $38.876B 28.67
STERIS (STE) Ireland $19.915B 23.57
Waters (WAT) United States $18.288B 26.24
Hologic (HOLX) United States $17.772B 19.61
SONOVA HOLDING (SONVY) Switzerland $16.481B 0.00
ShockWave Medical (SWAV) United States $12.303B 85.01
Fresenius Medical Care AG KGaA (FMS) Germany $11.860B 14.65
Sysmex ADR (SSMXY) Japan $9.975B 31.28
Teleflex (TFX) United States $9.736B 15.29
Penumbra (PEN) United States $7.965B 98.32
Masimo (MASI) United States $7.156B 40.13
Globus Medical (GMED) United States $6.819B 21.62
Glaukos (GKOS) United States $5.024B 0.00
Integer Holdings (ITGR) United States $3.724B 22.50
LivaNova (LIVN) United Kingdom $2.973B 19.61
TransMedics (TMDX) United States $2.920B 0.00
PROCEPT BioRobotics (PRCT) United States $2.687B 0.00
Elekta AB (EKTAY) Sweden $2.570B 17.63
Nihon Kohden (NHNKY) Japan $2.380B 20.13
Tandem Diabetes Care (TNDM) United States $2.296B 0.00
Integra LifeSciences Holdings (IART) United States $2.233B 9.16
Inari Medical (NARI) United States $2.207B 380.70
RxSight (RXST) United States $1.919B 0.00
Alphatec Holdings (ATEC) United States $1.689B 0.00
Veracyte (VCYT) United States $1.462B 0.00
OPKO Health (OPK) United States $0.850B 0.00
Artivion (AORT) United States $0.835B 96.52
AVANOS MEDICAL, INC (AVNS) United States $0.825B 15.26
Paragon 28 (FNA) United States $0.744B 0.00
OrthoPediatrics (KIDS) United States $0.712B 0.00
Silk Road Medical (SILK) United States $0.691B 0.00
Treace Medical Concepts (TMCI) United States $0.636B 0.00
SiBone (SIBN) United States $0.586B 0.00
Mesa Laboratories (MLAB) United States $0.549B 18.65
IRadimed (IRMD) United States $0.525B 30.49
ORTHOFIX MEDICAL INC (OFIX) United States $0.490B 0.00
Nevro (NVRO) United States $0.426B 0.00
NeuroPace (NPCE) United States $0.373B 0.00
Pulse Biosciences (PLSE) United States $0.369B 0.00
Tactile Systems Technology (TCMD) United States $0.339B 11.42
CVRx (CVRX) United States $0.311B 0.00
AxoGen (AXGN) United States $0.285B 0.00
EDAP TMS S.A (EDAP) France $0.275B 0.00
Sight Sciences (SGHT) United States $0.255B 0.00
AngioDynamics (ANGO) United States $0.232B 0.00
Accuray (ARAY) United States $0.216B 0.00
Atossa Genetics (ATOS) United States $0.190B 0.00
908 Devices (MASS) United States $0.183B 0.00
Semler Scientific (SMLR) United States $0.182B 9.81
Alpha Tau Medical (DRTS) Israel $0.167B 0.00
Inogen (INGN) United States $0.153B 0.00
ClearPoint Neuro (CLPT) United States $0.144B 0.00
Delcath Systems (DCTH) United States $0.134B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
Neuronetics (STIM) United States $0.106B 0.00
KORU Medical Systems (KRMD) United States $0.100B 0.00
Envoy Medical (COCH) United States $0.099B 0.00
Spectral Diagnostics (EDTXF) Canada $0.093B 0.00
Monogram Orthopaedics (MGRM) United States $0.075B 0.00
EnVVeno Medical (NVNO) United States $0.070B 0.00
Autonomix Medical (AMIX) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
SEP Acquisition (SEPA) United States $0.058B 0.00
Sensus Healthcare (SRTS) United States $0.055B 111.00
Vasomedical (VASO) United States $0.052B 9.33
Vicarious Surgical (RBOT) United States $0.046B 0.00
InspireMD (NSPR) Israel $0.045B 0.00
DarioHealth (DRIO) United States $0.044B 0.00
Aspira Women's Health (AWH) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
LENSAR (LNSR) United States $0.039B 0.00
Pixie Dust Technologies (PXDT) Japan $0.038B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Lucid Diagnostics (LUCD) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.017B 0.00
PAVmed (PAVM) United States $0.016B 0.00
T2 Biosystems (TTOO) United States $0.015B 0.00
Biosig Technologies (BSGM) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Microbot Medical (MBOT) United States $0.012B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00